Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, which includes the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to do so may possibly be grounds for compensation. Our lawyers are working tough to obtain those hurt by the drug the compensation they may be entitled to.













image class="left" url="https://images34.fotki.com/v1633/photos/2/3651632/13703394/torivaroxabansideeffects070915-vi.jpg"Although bleeding can be a frequent complication connected with anticoagulants, it has been alleged that Xarelto is more hazardous than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, individuals may be at risk for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.













Should you or a loved one suffered a serious bleeding occasion following taking Xarelto, you might have legal recourse. For far more data, get in touch with us these days to have your case reviewed, free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in situations of death, funeral expenditures. Additionally, they're searching for punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.






Why Are Lawsuits Getting Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a safe anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this Link Home Page for far more info on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki